Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Chemicals that cause cancer can’t be accurately studied

Josh Herigon, MPH
Conditions
July 1, 2010
Share
Tweet
Share

Nicholas Kristof in the New York Times writes about a new report from the President’s Cancer Panel calling attention to the role common chemicals may play in the development of cancer.

The overarching message is that we should be exercising much more caution in our trust of chemicals.

I am not familiar with the nuances of regulatory policies for chemicals, but (as Kristof points out) the “existing regulatory presumption [is] that chemicals are safe unless strong evidence emerges to the contrary.”  This approach seems insane to me.

We don’t approach the regulation of drugs this way, why are other chemicals different?  Unfortunately, changing this attitude is going to be nearly impossible given the heavy influence of chemical company lobbyists.

As important as I think the message of Kristof’s article is, I’m actually linking to this story to highlight an epidemiological problem inherent in almost any medical research attempting to link a chemical and cancer.  All such studies are observational, not experimental.

Ethically, we can’t randomize people to ingest what we think may be toxic chemicals.  Additionally, the development of cancer is slow.  Even if we ignored the ethical concerns, participants would need to be followed for decades.  Such follow-up is expensive and frequently suboptimal (participants are often “lost” when they move or simply drop-out of the study for various reasons which can bias results).

Fortunately, case-control studies were designed to overcome these very problems.  The drawback to case-control studies is that it’s difficult to measure a person’s exposure to a given chemical.  It’s generally impossible to measure it directly and asking somebody if they used a product years ago is obviously not very accurate.

Research has had success in linking some chemicals to specific diseases.  Such success has been largely limited to instances of occupational exposure.  Why?  Simply because it is easy to measure somebody’s exposure to a chemical if it happens in the work place.  Employment records can pinpoint when I person worked in a specific position and by re-creating their working conditions you can measure how much daily exposure they received.  Multiply this by the amount of time they worked there and you can easily create a relatively accurate picture of their exposure.  These studies have also been successful because workers generally receive huge doses of these chemicals and manifest severe symptoms much more quickly than the general public which may have a tiny fraction of the exposure.

This report from the President’s Cancer Panel and Kristof’s subsequent op-ed are likely to engender what may become a vitriolic debate about chemicals and their health consequences.  Undoubtedly, chemical proponents will point out that the research linking chemicals and cancer has methodological problems.  They will not be incorrect in this criticism.  When deciding for yourself, realize there are some inherent problems in trying to establish a direct, clear-cut, causal link between a given chemical and its possible impact on human health.

We can’t do a randomized clinical trial injecting one group with BPA to see if they develop cancer.  Also realize that we didn’t have to do a randomized clinical trial of smoking to establish its link to lung cancer.  As more researchers tackle this challenging problem, more evidence will emerge and recommendations will be revised.

In the meantime, I will be trusting the advice of some accomplished doctors and not that of big chemical companies.

Josh Herigon is a medical student who blogs a Number Needed to Treat.

Submit a guest post and be heard.

ADVERTISEMENT

Prev

Customer service needs to be a priority in health care

July 1, 2010 Kevin 73
…
Next

Op-ed: Paying patients to stay healthy widens the wealth gap

July 2, 2010 Kevin 0
…

Tagged as: Medications, Oncology/Hematology

Post navigation

< Previous Post
Customer service needs to be a priority in health care
Next Post >
Op-ed: Paying patients to stay healthy widens the wealth gap

ADVERTISEMENT

More by Josh Herigon, MPH

  • a desk with keyboard and ipad with the kevinmd logo

    Did the NEJM publish a bad study about checklists?

    Josh Herigon, MPH
  • a desk with keyboard and ipad with the kevinmd logo

    The threat of technology to proper patient care

    Josh Herigon, MPH
  • a desk with keyboard and ipad with the kevinmd logo

    How social media will merge with electronic medical records

    Josh Herigon, MPH

More in Conditions

  • How President Biden’s cognitive health shapes political and legal trust

    Muhamad Aly Rifai, MD
  • The emotional first responders of aesthetic medicine

    Sarah White, APRN
  • Why testosterone matters more than you think in women’s health

    Andrea Caamano, MD
  • How veteran health care is being transformed by tech and teamwork

    Deborah Lafer Scher
  • What Elon Musk and Diddy reveal about the price of power

    Osmund Agbo, MD
  • Understanding depression beyond biology: the power of therapy and meaning

    Maire Daugharty, MD
  • Most Popular

  • Past Week

    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
    • How New Mexico became a malpractice lawsuit hotspot

      Patrick Hudson, MD | Physician
    • Why doctors are reclaiming control from burnout culture

      Maureen Gibbons, MD | Physician
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy
    • How digital tools are reshaping the doctor-patient relationship

      Vineet Vishwanath | Tech
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
  • Past 6 Months

    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
    • Why Medicaid cuts should alarm every doctor

      Ilan Shapiro, MD | Policy
  • Recent Posts

    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Decoding your medical bill: What those charges really mean

      Cheryl Spang | Finance
    • The emotional first responders of aesthetic medicine

      Sarah White, APRN | Conditions
    • Why testosterone matters more than you think in women’s health

      Andrea Caamano, MD | Conditions
    • A mind to guide the machine: Why physicians must help shape artificial intelligence in medicine

      Shanice Spence-Miller, MD | Tech
    • How subjective likability practices undermine Canada’s health workforce recruitment and retention

      Olumuyiwa Bamgbade, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
    • How New Mexico became a malpractice lawsuit hotspot

      Patrick Hudson, MD | Physician
    • Why doctors are reclaiming control from burnout culture

      Maureen Gibbons, MD | Physician
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy
    • How digital tools are reshaping the doctor-patient relationship

      Vineet Vishwanath | Tech
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
  • Past 6 Months

    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
    • Why Medicaid cuts should alarm every doctor

      Ilan Shapiro, MD | Policy
  • Recent Posts

    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Decoding your medical bill: What those charges really mean

      Cheryl Spang | Finance
    • The emotional first responders of aesthetic medicine

      Sarah White, APRN | Conditions
    • Why testosterone matters more than you think in women’s health

      Andrea Caamano, MD | Conditions
    • A mind to guide the machine: Why physicians must help shape artificial intelligence in medicine

      Shanice Spence-Miller, MD | Tech
    • How subjective likability practices undermine Canada’s health workforce recruitment and retention

      Olumuyiwa Bamgbade, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Chemicals that cause cancer can’t be accurately studied
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...